Euphoria Formulation Private Limited
Pharmaceutical trading company incorporated in 2005, based in Mumbai, Maharashtra.
2005 | Mumbai, Maharashtra (India) | Active
Euphoria Formulation Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.07 Cr
- Satisfied Charges ₹ 2.00 M
- Revenue Growth 3.37%
- Profit Growth 19.05%
- Ebitda -23.33%
- Net Worth 27.58%
- Total Assets 19.17%
About Euphoria Formulation
Euphoria Formulation Private Limited (EFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 June 2005 and has a history of 19 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.07 Cr. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Nikhil Jain and Mishrimal Jain serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51397MH2005PTC154012
- Company No.
154012
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2005
- Date of AGM
24 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Euphoria Formulation?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Jain  | Director | 21-Jun-2011 | Current |
| Mishrimal Jain | Director | 08-Sep-2009 | Current |
Financial Performance of Euphoria Formulation.
Euphoria Formulation Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.37% increase. The company also saw a substantial improvement in profitability, with a 19.05% increase in profit. The company's net worth Soared by an impressive increase of 27.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Euphoria Formulation?
Unlock access to Euphoria Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Nimiva Infra Llp
Nikhil Jain is a mutual person
Charges (Loans)
Open Charges
₹20.70 M
Satisfied Charges
₹2.00 M
Charges Breakdown by Lending Institutions
- Others : 2.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2010 | Others | ₹2.07 Cr | Open |
| 23 Feb 2006 | Vijaya Bank | ₹2.00 M | Satisfied |
How Many Employees Work at Euphoria Formulation?
Unlock and access historical data on people associated with Euphoria Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Euphoria Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euphoria Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Euphoria Formulation
Recent activity within the organization
- Annual General Meeting
Euphoria Formulation Private Limited last Annual general meeting of members was held on 24 Sep 2023 as per latest MCA records.
- Balance Sheet
Euphoria Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
- Charges
A charge with Others of Rs. 20.70 M registered on 09 Jun 2010 with Charge ID 10230991 was modified on 16 Jun 2020.
- Charges
A charge registered on 23 Feb 2006 via Charge ID 90354693 with Vijaya Bank was fully satisfied on 01 Jul 2011.
- Director Appointment
Nikhil Jain was appointed as a Director was appointed as a Director on 21 Jun 2011 & has been associated with this company since 13 years 8 months .
- Charges
A charge with Others amounted to Rs. 20.70 M with Charge ID 10230991 was registered on 09 Jun 2010.
Frequently asked questions
What is the Incorporation or founding date of Euphoria Formulation Private Limited?
Euphoria Formulation Private Limited was incorporated on 16 Jun 2005.
What is authorized share capital and paid-up capital of Euphoria Formulation Private Limited?
The authorized share capital of Euphoria Formulation Private Limited is ₹ 2.00 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Euphoria Formulation Private Limited?
Currently 2 directors are associated with Euphoria Formulation Private Limited.
- Nikhil Jain
- Mishrimal Valchand Jain
What is the registered address of Euphoria Formulation Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Euphoria Formulation Private Limited is 1/12 Varma Nagar Old Nagardas Road Andheri East, India, Mumbai, Maharashtra, 400069.
What is the corporate identification number (CIN) and company number of Euphoria Formulation Private Limited?
The corporate identification number (CIN) of Euphoria Formulation Private Limited is U51397MH2005PTC154012 and the company number is 154012 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Euphoria Formulation Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Euphoria Formulation Private Limited has risen by 3.37%.
What change has been observed in the net worth of Euphoria Formulation Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Euphoria Formulation Private Limited has experienced an upsurge of 27.58%.
What are the total open charges for Euphoria Formulation Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Euphoria Formulation Private Limited amount to ₹ 2.07 Cr.
When was the last Balance Sheet of Euphoria Formulation Private Limited filed with the ROC?
The most recent Balance Sheet for Euphoria Formulation Private Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
BS
Bhavesh ShahDirectorCJ
Chirag JainDirector